Chromocell Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Frank Knuettel
Chief executive officer
US$110.0k
Total compensation
| CEO salary percentage | 97.7% |
| CEO tenure | 2yrs |
| CEO ownership | 2.2% |
| Management average tenure | no data |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$9m |
| Dec 31 2023 | US$110k | US$108k | -US$7m |
| Sep 30 2023 | n/a | n/a | -US$5m |
| Jun 30 2023 | n/a | n/a | -US$4m |
| Mar 31 2023 | n/a | n/a | -US$3m |
| Dec 31 2022 | US$54k | US$30k | -US$2m |
Compensation vs Market: Frank's total compensation ($USD109.99K) is below average for companies of similar size in the US market ($USD681.24K).
Compensation vs Earnings: Frank's compensation has increased whilst the company is unprofitable.
CEO
Frank Knuettel (58 yo)
2yrs
Tenure
US$109,989
Compensation
Mr. Francis Knuettel II, also known as Frank, M.B.A. serves as a Director at Capstone Technologies Group, Inc. since November 2023. He serves as Chief Financial Officer at Semper Paratus Acquisition Corpor...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 1.4yrs | US$748.04k | 0.50% $ 43.8k | |
| Chair of Scientific Advisory Board | no data | no data | no data | |
| Chair of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.3yrs | US$336.61k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$374.02k | 17.72% $ 1.6m | |
| Independent Director | 1.4yrs | US$374.02k | 0% $ 0 |
1.4yrs
Average Tenure
58.5yo
Average Age
Experienced Board: CHRO's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.